Desq Long
Sign in

Company

Medpace Holdings, Inc.

MEDP · CIK 0001668397

SEC FORM 4
$17,293,477.89

Medpace Holdings, Inc. (MEDP)

Sale of 27,833 shares at $621.33 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001622058-26-000018 · filed 2026-09-25 · View filing →

SEC FORM 4
$10,110,417.12

Medpace Holdings, Inc. (MEDP)

Sale of 16,083 shares at $628.64 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001622058-26-000018 · filed 2026-09-25 · View filing →

SEC FORM 4
$30,788,695.98

Medpace Holdings, Inc. (MEDP)

Sale of 49,018 shares at $628.11 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001622058-26-000016 · filed 2026-09-23 · View filing →

SEC FORM 4
$13,639,455.07

Medpace Holdings, Inc. (MEDP)

Sale of 21,883 shares at $623.29 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001622058-26-000016 · filed 2026-09-23 · View filing →

SEC FORM 4
$6,749,952.00

Medpace Holdings, Inc. (MEDP)

Sale of 10,880 shares at $620.40 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001622058-26-000014 · filed 2026-09-21 · View filing →

SEC FORM 4
$5,448,713.30

Medpace Holdings, Inc. (MEDP)

Sale of 8,770 shares at $621.29 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001622058-26-000012 · filed 2026-09-17 · View filing →

SEC FORM 4
$9,915,435.64

Medpace Holdings, Inc. (MEDP)

Sale of 15,971 shares at $620.84 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001622058-26-000012 · filed 2026-09-17 · View filing →

SEC FORM 4
$500,190.00

Medpace Holdings, Inc. (MEDP)

Acquisition (code M) of 3,000 shares at $166.73 per share.

Reporting Person BURWIG SUSAN E · Officer Title Exec. VP, Operations · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001677418-26-000010 · filed 2026-09-17 · View filing →

SEC FORM 4
$403,175.50

Medpace Holdings, Inc. (MEDP)

Sale of 650 shares at $620.27 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001622058-26-000010 · filed 2026-08-31 · View filing →

SEC FORM 4
$325,460.88

Medpace Holdings, Inc. (MEDP)

Acquisition (code M) of 3,858 shares at $84.36 per share.

Reporting Person Kraft Robert O. · Transaction Code M

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001558592-26-000010 · filed 2026-08-28 · View filing →

SEC FORM 4
$2,383,510.98

Medpace Holdings, Inc. (MEDP)

Sale of 3,858 shares at $617.81 per share.

Reporting Person Kraft Robert O. · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001558592-26-000010 · filed 2026-08-28 · View filing →

SEC FORM 4
$2,480,120.00

Medpace Holdings, Inc. (MEDP)

Sale of 4,000 shares at $620.03 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001622058-26-000008 · filed 2026-08-27 · View filing →

SEC FORM 4
$417,515.74

Medpace Holdings, Inc. (MEDP)

Sale of 673 shares at $620.38 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001622058-26-000008 · filed 2026-08-27 · View filing →

SEC FORM 4
$1,229,916.09

Medpace Holdings, Inc. (MEDP)

Sale of 1,983 shares at $620.23 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0000892251-26-000152 · filed 2026-08-25 · View filing →

SEC FORM 4
$8,739,177.75

Medpace Holdings, Inc. (MEDP)

Sale of 13,995 shares at $624.45 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0000892251-26-000152 · filed 2026-08-25 · View filing →

SEC FORM 4
$472,158.00

Medpace Holdings, Inc. (MEDP)

Acquisition (code M) of 3,400 shares at $138.87 per share.

Reporting Person Brady Kevin M. · Officer Title CFO & Treasurer · Transaction Code M

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0000892251-26-000149 · filed 2026-08-24 · View filing →

SEC FORM 4
$2,125,816.00

Medpace Holdings, Inc. (MEDP)

Sale of 3,400 shares at $625.24 per share.

Reporting Person Brady Kevin M. · Officer Title CFO & Treasurer · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0000892251-26-000149 · filed 2026-08-24 · View filing →

SEC FORM 4
$16,814,999.46

Medpace Holdings, Inc. (MEDP)

Sale of 27,174 shares at $618.79 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000892251-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$254,754.61

Medpace Holdings, Inc. (MEDP)

Acquisition (code M) of 1,903 shares at $133.87 per share.

Reporting Person DAVENPORT FRED B JR · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000892251-26-000123 · filed 2026-08-21 · View filing →

SEC FORM 4
$325,460.88

Medpace Holdings, Inc. (MEDP)

Acquisition (code M) of 3,858 shares at $84.36 per share.

Reporting Person DAVENPORT FRED B JR · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000892251-26-000123 · filed 2026-08-21 · View filing →

SEC FORM 4
$300,046.96

Medpace Holdings, Inc. (MEDP)

Acquisition (code M) of 1,822 shares at $164.68 per share.

Reporting Person DAVENPORT FRED B JR · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000892251-26-000123 · filed 2026-08-21 · View filing →

SEC FORM 4
$4,414,590.45

Medpace Holdings, Inc. (MEDP)

Sale of 7,283 shares at $606.15 per share.

Reporting Person DAVENPORT FRED B JR · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000892251-26-000123 · filed 2026-08-21 · View filing →

SEC FORM 4
$3,043,150.00

Medpace Holdings, Inc. (MEDP)

Sale of 5,000 shares at $608.63 per share.

Reporting Person Carley Brian T · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000892251-26-000124 · filed 2026-08-21 · View filing →

SEC FORM 4
$9,466,390.23

Medpace Holdings, Inc. (MEDP)

Sale of 15,609 shares at $606.47 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000892251-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$274,978.62

Medpace Holdings, Inc. (MEDP)

Sale of 458 shares at $600.39 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000892251-26-000114 · filed 2026-08-14 · View filing →

SEC FORM 4
$6,836,989.98

Medpace Holdings, Inc. (MEDP)

Sale of 11,366 shares at $601.53 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000892251-26-000114 · filed 2026-08-14 · View filing →

SEC FORM 4
$690,121.80

Medpace Holdings, Inc. (MEDP)

Sale of 1,140 shares at $605.37 per share.

Reporting Person McCarthy Cornelius P. III · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001750355-26-000012 · filed 2026-08-13 · View filing →

SEC FORM 4
$10,655,987.10

Medpace Holdings, Inc. (MEDP)

Sale of 17,610 shares at $605.11 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001622058-26-000006 · filed 2026-08-12 · View filing →

SEC FORM 4
$3,328,867.02

Medpace Holdings, Inc. (MEDP)

Sale of 5,534 shares at $601.53 per share.

Reporting Person Troendle August J. · Officer Title President & CEO · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001622058-26-000006 · filed 2026-08-12 · View filing →

STOCK ACT PTR
$1,001 - $15,000

Medpace Holdings Inc (MEDP)

Purchase.

Filer David Taylor · Chamber House · District OH02 · Transaction Type Purchase · Asset Type Stock

Traded May 15, 2026 · Disclosed May 28, 2026FILED +13 DAYS

Source: House Clerk PTR · 20034650 · filed 2026-05-28 · View filing →

STOCK ACT PTR
$1,001 - $15,000

Medpace Holdings Inc (1) (MEDP)

Purchase.

Filer David Taylor · Chamber House · District OH02 · Transaction Type Purchase · Asset Type Stock

Traded May 15, 2026 · Disclosed May 28, 2026FILED +13 DAYS

Source: House Clerk PTR · 20034650 · filed 2026-05-28 · View filing →

STOCK ACT PTR
$1,001 - $15,000

Medpace Holdings Inc (2) (MEDP)

Purchase.

Filer David Taylor · Chamber House · District OH02 · Transaction Type Purchase · Asset Type Stock

Traded May 15, 2026 · Disclosed May 28, 2026FILED +13 DAYS

Source: House Clerk PTR · 20034650 · filed 2026-05-28 · View filing →